CTNNB1 and thyroid gland carcinoma: For example, Wang et al. (2018) suggested that circ-ITCH inhibited progression of PTC through the miR-22-3p/CBL/beta-catenin pathway; Bi et al. (2018) showed that circRNA_102171 promoted the progression of PTC by regulating CTNNB1P1-dependent activation of the beta-catenin pathway; Liu et al. (2018) also indicated that hsa_circ_0060060 enhanced cisplatin resistance of human thyroid carcinoma cells by autophagy regulation.